Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.79 |
| ▸ | MEN1 | O00255 | 1/20 | 0.79 |
| ▸ | ABL1 | P00519 | 1/20 | 0.79 |
| ▸ | LMNA | P02545 | 1/20 | 0.79 |
| ▸ | PKM | P14618 | 1/20 | 0.79 |
| ▸ | IDE | P14735 | 1/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.79 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.79 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.79 |
| ▸ | HLCS | P50747 | 6/20 | 0.72 |
| ▸ | CA12 | O43570 | 7/20 | 0.50 |
| ▸ | CA1 | P00915 | 7/20 | 0.50 |
| ▸ | CA2 | P00918 | 7/20 | 0.50 |
| ▸ | CA9 | Q16790 | 7/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biotin SCHEMBL987288 | 1.00 | TDP1 (0.79) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL8651197 | 0.95 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL6033491 | 0.95 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL8672968 | 0.94 | TDP1 (0.85) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL23722253 | 0.94 | TDP1 (0.90) | TDP1MEN1ABL1LMNAPKM | |
| Stearic Acid SCHEMBL10828834 | 0.93 | TDP1 (0.83) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL4957081 | 0.93 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL3518095 | 0.93 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL27671459 | 0.93 | TDP1 (0.87) | TDP1MEN1ABL1LMNAPKM | |
| Biotin SCHEMBL715457 | 0.92 | TDP1 (0.77) | TDP1MEN1ABL1LMNAPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114524875-B | Nano silicon sphere coupled with IL-1 beta monoclonal antibody and application thereof | 江苏莱森生物科技研究院有限公司 | 2023-07-25 | — | — | CN | disclosed |
| US-20170240887-A1 | LIGAND SCREENING AND DISCOVERY | DYAX CORP. (US) | 2017-08-24 | — | — | US | disclosed |
| US-9562902-B2 | Ligand screening and discovery | DYAX CORP. (US) | 2017-02-07 | — | — | US | disclosed |
| US-20150087533-A1 | LIGAND SCREENING AND DISCOVERY | DYAX CORP. (US) | 2015-03-26 | — | — | US | disclosed |
| US-8846579-B2 | Ligand screening and discovery | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-09-30 | — | — | US | disclosed |
| US-20130274112-A1 | LIGAND SCREENING AND DISCOVERY | DYAX CORP. | 2013-10-17 | — | — | US | disclosed |
| US-8445410-B2 | Ligand screening and discovery | DYAX CORP. (US) | 2013-05-21 | — | — | US | disclosed |
| US-20090105083-A1 | Ligand Screening and Discovery | DYAX CORP., A DELAWARE CORPORATION | 2009-04-23 | — | — | US | disclosed |
| US-7244592-B2 | Identifying immunoglobulins for use as therapeutic, diagnostic an/or affinity separation agents; in vitro translation | DYAX CORP. (US) | 2007-07-17 | — | — | US | disclosed |
| US-20030224408-A1 | Identifying immunoglobulins for use as therapeutic, diagnostic an/or affinity separation agents; in vitro translation | DYAX CORPORATION | 2003-12-04 | — | — | US | disclosed |